Correction to: Cancer Cell Int (2021) 21:458 https://doi.org/10.1186/s12935-021-02162-w

In this article [1], the author would like to correct the two mistakes mentioned below with this erratum.

In the methods section, “LAG-3 (1:200, ab101500, Abcam, Cambridge, MA)” should be changed to “LAG-3 (1:200, ab180187, Abcam, Cambridge, MA)”.

In the Table 2 section, the title “Expression of LAG-3, PD-1, and PD-L1, CD3, GZMB in NSCLC patients” should be changed to “Expression of LAG-3, PD-1, and PD-L1, CD3, GZMB in NPC patients”. Correspondingly, “NSCLC: non-small cell lung cancer” should be changed to “NPC: nasopharyngeal carcinoma” in the caption of the table.